Translation termination and protein folding pathway genes are not correlated in gastric cancer

Clinical Chemistry and Laboratory Medicine

Volumn 47, Issue 4, 2009, Pages 427-431

  Malta Vacas, Joana ^a   Nolasco, Sofia ^b   Monteiro, Carolino ^c   Soares, Helena ^a,b   Brito, Miguel ^a  

^a INSTITUTO POLITÉCNICO DE LISBOA   (Portugal)

^b INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

^c RESEARCH INSTITUTE FOR MEDICINES IMED ULISBOA   (Portugal)

Author keywords

CCT subunits; Eukaryotic release factor 3a G to S phase transition 1 (eRF3a GSPT1); Gastric cancer; Protein folding pathways; Translation termination

Indexed keywords

CELL PROTEIN; CHAPERONIN CONTAINING TCP 1 2; CHAPERONIN CONTAINING TCP 1 4; EUKARYOTIC RELEASE FACTOR 3; MESSENGER RNA; PROTEIN G TO S PHASE TRANSITION 1; PROTEIN PREFOLDIN; TUBULIN; TUBULIN COFACTOR A; UNCLASSIFIED DRUG;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTESTINE TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; RNA TRANSLATION; STOMACH CANCER;

GENE EXPRESSION REGULATION, NEOPLASTIC; PROTEIN BIOSYNTHESIS; PROTEIN FOLDING; RNA, MESSENGER; STOMACH NEOPLASMS;

EUKARYOTA;

EID: 63849240399     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2009.091     Document Type: Article

References (23)

1. Zhouravleva G, Frolova L, Le Goff X, Le Guellec R, Inge-Vechtomov S, Kisselev L, et al. Termination of translation in eukaryotes is governed by two interacting polypeptide chain release factors, eRF1 and eRF3. EMBO J 1995;14: 4065-72.
2. Simons CT, Staes A, Rommelaere H, Ampe C, Lewis SA, Cowan NJ. Selective contribution of eukaryotic prefoldin subunits to actin and tubulin binding. J Biol Chem 2004;279:4196-203.
3. Vainberg IE, Lewis SA, Rommelaere H, Ampe C, Vandekerckhove J, Klein HL, et al. Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. Cell 1998;93:863-73.
4. Kubota H. Function and regulation of cytosolic molecular chaperone CCT. Vitam Horm 2002;65:313-31.
5. Tian G, Lewis SA, Feierbach B, Stearns T, Rommelaere H, Ampe C, et al. Tubulin subunits exist in an activated conformational state generated and maintained by protein cofactors. J Cell Biol 1997;138:821-32.
6. Thulasiraman V, Yang C, Frydman J. In vivo newly translated polypeptides are sequestered in a protected folding environment. EMBO J 1999;18:85-95.
7. López-Fanarraga M, Avila J, Guasch A, Coll M, Zabala JC. Postchaperonin tubulin folding cofactors and their role in microtubule dynamics. J Struct Biol 2001;135: 219-29.
8. Cunningham LA, Kahn RA. Cofactor D functions as a centrosomal protein and is required for the recruitment of the γ-tubulin ring complex at centrosomes and organization of the mitotic spindle. J Biol Chem 2008;283: 7155-65.
9. Nolasco S, Bellido J, Goncalves J, Zabala JC, Soares H. Tubulin cofactor A gene silencing in mammalian cells induces changes in microtubule cytoskeleton, cell cycle arrest and cell death. FEBS Lett 2005;579:3515-24.
10. Eisenberg D, Marcotte EM, Xenarios I, Yeates TO. Protein function in the post-genomic era. Nature 2000;405: 823-6.
11. King MD, Roobol A, Carden MJ. Confirmation of an interaction between eRF3 (Sup35p/GSPT1) and chaperonin CCT. Mol Biol Cell 2000;11S:617.
12. Basu J, Williams BC, Li Z, Williams EV, Goldberg ML. Depletion of a drosophila homolog of yeast Sup35p disrupts spindle assembly, chromosome segregation, and cytokinesis during male meiosis. Cell Motil Cytoskeleton 1998;39:286-302.
13. Borhsenius AG, Tchourikova AA, Inge-Vechtomov SG. Recessive mutations in SUP35 and SUP45 genes coding for translation release factors affect chromosome stability in Saccharomyces cerevisiae. Curr Genet 2000;37: 285-91.
14. Valouev IA, Kushnirov VV, Ter-Avanesyan MD. Yeast polypeptide chain release factors eRF1 and eRF3 are involved in cytoskeleton organization and cell cycle regulation. Cell Motil Cytoskeleton 2002;52:161-73.
15. Chai B, Wang W, Liang A. Nuclear localization of eukaryotic class II release factor (eRF3): implication for the multifunction of eRF3 in ciliates Euplotes cell. Cell Biol Int 2008;32:353-7.
16. Hoshino S, Imai M, Mizutani M, Kikuchi Y, Hanaoka F, Ui M, et al. Molecular cloning of a novel member of the eukaryotic polypeptide chain-releasing factors (eRF). Its identification as eRF3 interacting with eRF1. J Biol Chem 1998;273:22254-9.
17. Chauvin C, Salhi S, Jean-Jean O. Human eukaryotic release factor 3a depletion causes cell cycle arrest at G1 phase through inhibition of the mTOR pathway. Mol Cell Biol 2007;27:5619-29.
18. Yokota S, Yanagi H, Yura T, Kubota H. Cytosolic chaperonin is upregulated during cell growth: preferential expression and binding to tubulin at G1/S transition through early S phase. J Biol Chem 1999;274:37070-8.
19. Malta-Vacas J, Aires C, Costa P, Conde AR, Ramos S, Martins AP, et al. Differential expression of the eukaryotic release factor 3 (eRF3/GSPT1) according to gastric cancer histological types. J Clin Pathol 2005;58:621-5.
20. Yokota S, Yamamoto Y, Shimizu K, Momoi H, Kamikawa T, Yamaoka Y, et al. Increased expression of cytosolic chaperonin CCT in human hepatocellular and colonic carcinoma. Cell Stress Chaperones 2001;6:345-50.
21. Werner M, Becker KF, Keller G, Hofler H. Gastric adenocarcinoma: pathomorphology and molecular pathology. J Cancer Res Clin Oncol 2001;127:207-16.
22. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001;25:402-8.
23. Martín-Benito J, Boskovic J, Gómez-Puertas P, Carrascosa J, Simons CT, Lewis SA, et al. Structure of eukaryotic prefoldin and of its complexes with unfolded actin and the cytosolic chaperonin CCT. EMBO J 2002;21: 6377-86.